Skip to main content

Adhera Therapeutics, Inc. (ATRX)

OTCMKTS: ATRX · Delayed Price · USD
0.1800 0.0400 (28.57%)
Sep 17, 2021 3:59 PM EDT - Market closed
Market Cap2.09M
Revenue (ttm)132,000
Net Income (ttm)-4.01M
Shares Out11.67M
EPS (ttm)-0.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume342,127
Open0.1953
Previous Close0.1400
Day's Range0.1500 - 0.1953
52-Week Range0.0340 - 0.2500
Beta0.57
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ATRX

Adhera Therapeutics, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

IndustryBiotechnology
CountryUnited States
Stock ExchangeOTCMKTS
Ticker SymbolATRX
Full Company Profile

Financial Performance

Financial Statements

News

Adhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson's Disease and Type 1 Diabetes Drugs

Baton Rouge, LA, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, today provides shareholders an update...

1 week ago - GlobeNewsWire